Correlation Between MediciNova and Cyteir Therapeutics
Can any of the company-specific risk be diversified away by investing in both MediciNova and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MediciNova and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MediciNova and Cyteir Therapeutics, you can compare the effects of market volatilities on MediciNova and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MediciNova with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MediciNova and Cyteir Therapeutics.
Diversification Opportunities for MediciNova and Cyteir Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between MediciNova and Cyteir is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding MediciNova and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and MediciNova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MediciNova are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of MediciNova i.e., MediciNova and Cyteir Therapeutics go up and down completely randomly.
Pair Corralation between MediciNova and Cyteir Therapeutics
If you would invest 195.00 in MediciNova on November 20, 2024 and sell it today you would earn a total of 2.00 from holding MediciNova or generate 1.03% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
MediciNova vs. Cyteir Therapeutics
Performance |
Timeline |
MediciNova |
Cyteir Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
MediciNova and Cyteir Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MediciNova and Cyteir Therapeutics
The main advantage of trading using opposite MediciNova and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MediciNova position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.MediciNova vs. Aerovate Therapeutics | MediciNova vs. Adagene | MediciNova vs. Acrivon Therapeutics, Common | MediciNova vs. Rezolute |
Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
CEOs Directory Screen CEOs from public companies around the world |